g(m1)-oligosaccharide has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
*1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. [MeSH]
*1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. [MeSH]
| Studies (g(m1)-oligosaccharide) | Trials (g(m1)-oligosaccharide) | Recent Studies (post-2010) (g(m1)-oligosaccharide) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
|---|---|---|---|---|---|
| 17 | 1 | 5 | 3,859 | 8 | 1,052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiricozzi, E; di Biase, E; Elisa, M; Fazzari, M; Loberto, N; Lunghi, G; Maggioni, M; Scalvini, FG; Sonnino, S; Tedeschi, G | 1 |
1 other study(ies) available for g(m1)-oligosaccharide and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
The Neuroprotective Role of the GM1 Oligosaccharide, II
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Mice; Mitochondria; Models, Biological; Neoplasm Proteins; Neuroblastoma; Neuroprotection; Neuroprotective Agents; Oligosaccharides; Oxidative Stress; Proteomics; Reactive Oxygen Species; Receptor, trkA; Swine | 2019 |